preloader icon



Apex Trader Funding - News

GeneDx Stock Climbs After Better-Than-Expected Q1 Results, Raises FY24 Guidance

GeneDx Holdings Corp. (NASDAQ:WGS) shares are soaring after the company reported its first-quarter financial results after the bell Monday. Here's a look at the highlights.  The Details: GeneDx reported quarterly losses of 33 cents per share which beat the analyst consensus estimate of losses of 67 cents by 50.75%. The company reported quarterly sales of $62.422 million which beat the analyst consensus estimate of $49.463 million by 26.2% and represents a 44.7% ...